Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (111-120 of 243) with videos related to

Pageof 25
Sort By:
Transplantation|December 23, 2003
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantationFrédéric Baron, Nicole Schaaf-Lafontaine, Stéphanie Humblet-Baron, et al.
International Orthopaedics|November 27, 2012
(111)Indium-oxine labelling for evaluating the homing process of autologous osteoblasts implanted percutaneously in atrophic nonunion fracturesJean-Philippe Hauzeur, Claire Bernard, Dominique Egrise, et al.
Journal of Crohn'S & Colitis|February 3, 2023
Clinical and MRI Evolution After Local Injection of Bone Marrow-Derived Mesenchymal Stem Cells in Perianal Fistulae in Crohn's Disease: Results From a Prospective Monocentric StudyCatherine Reenaers, Romain P Gillard, Carla Coimbra, et al.
Current Research in Translational Medicine|January 20, 2024
Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantationFiras Bayoudh, Jean-Baptiste Giot, Julie Descy, et al.
Frontiers in Immunology|July 21, 2022
Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical TrialCéline Grégoire, Nathalie Layios, Bernard Lambermont, et al.
Frontiers in Immunology|March 21, 2022
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised PatientsFrédéric Baron, Lorenzo Canti, Kevin K Ariën, et al.
Revue Medicale Suisse|August 24, 2018
[What is new in the management of multiple myeloma]Louise Vrancken, Joséphine Muller, Margaux Lejeune, et al.
Journal of Hematology & Oncology|November 3, 2021
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myelomaElodie Duray, Margaux Lejeune, Frederic Baron, et al.
Revue Medicale De Liege|February 17, 2023
[Delayed graft function : an ongoing clinical challenge]Pauline Erpicum, Tiago Pinto Coelho, Catherine Bonvoisin, et al.
American Journal of Hematology|March 25, 2015
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantationAurélie Jaspers, Frédéric Baron, Johan Maertens, et al.
Pageof 25

Showing results (111-120 of 243) with videos related to

Sort By:
Pageof 25
Transplantation|December 23, 2003
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantationFrédéric Baron, Nicole Schaaf-Lafontaine, Stéphanie Humblet-Baron, et al.
International Orthopaedics|November 27, 2012
(111)Indium-oxine labelling for evaluating the homing process of autologous osteoblasts implanted percutaneously in atrophic nonunion fracturesJean-Philippe Hauzeur, Claire Bernard, Dominique Egrise, et al.
Journal of Crohn'S & Colitis|February 3, 2023
Clinical and MRI Evolution After Local Injection of Bone Marrow-Derived Mesenchymal Stem Cells in Perianal Fistulae in Crohn's Disease: Results From a Prospective Monocentric StudyCatherine Reenaers, Romain P Gillard, Carla Coimbra, et al.
Current Research in Translational Medicine|January 20, 2024
Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantationFiras Bayoudh, Jean-Baptiste Giot, Julie Descy, et al.
Frontiers in Immunology|July 21, 2022
Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical TrialCéline Grégoire, Nathalie Layios, Bernard Lambermont, et al.
Frontiers in Immunology|March 21, 2022
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised PatientsFrédéric Baron, Lorenzo Canti, Kevin K Ariën, et al.
Revue Medicale Suisse|August 24, 2018
[What is new in the management of multiple myeloma]Louise Vrancken, Joséphine Muller, Margaux Lejeune, et al.
Journal of Hematology & Oncology|November 3, 2021
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myelomaElodie Duray, Margaux Lejeune, Frederic Baron, et al.
Revue Medicale De Liege|February 17, 2023
[Delayed graft function : an ongoing clinical challenge]Pauline Erpicum, Tiago Pinto Coelho, Catherine Bonvoisin, et al.
American Journal of Hematology|March 25, 2015
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantationAurélie Jaspers, Frédéric Baron, Johan Maertens, et al.
Pageof 25